PARATEK PHARMACEUTICALS INC (PRTK) Forecast, Price Target & Analyst Ratings
NASDAQ:PRTK • US6993743029
2.23 USD
+0.04 (+1.83%)
At close: Sep 20, 2023
2.23 USD
0 (0%)
After Hours: 9/20/2023, 8:00:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PARATEK PHARMACEUTICALS INC (PRTK).
Forecast Snapshot
Consensus Price Target
$3.16
+ 41.79% Upside
Next Earnings Forecast
Release DateNov 1, 2023
PeriodQ3 / 2023
EPS Estimate-$0.25
Revenue Estimate39.602M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.16
Upside
+ 41.79%
From current price of $2.23 to mean target of $3.16, Based on 9 analyst forecasts
Low
$2.17
Median
$2.19
High
$5.25
Price Target Revisions
1 Month
0.00%
3 Months
-41.87%
Price Target Summary
9 analysts have analysed PRTK and the average price target is 3.16 USD. This implies a price increase of 41.79% is expected in the next year compared to the current price of 2.23.
The average price target has been revised downward by 41.87% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PRTK was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PRTK.
In the previous month the buy percentage consensus was at a similar level.
PRTK was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-07-10 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-06-07 | Jefferies | Downgrade | Buy -> Hold |
| 2023-06-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-06 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-10 | WBB Securities | Upgrade | Buy -> Strong Buy |
| 2021-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-23 | WBB Securities | Upgrade | Speculative Buy -> Buy |
| 2021-03-02 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 1, 2023
PeriodQ3 / 2023
EPS Estimate-$0.25
Revenue Estimate39.602M
Revenue Q2Q31.08%
EPS Q2Q34.24%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
1.68%
EPS (1 Month)
0.00%
EPS (3 Months)
6.96%
Next Earnings Summary
PRTK is expected to report earnings on 11/1/2023. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 39.60M USD.
The next earnings revenue estimate has been revised upward by 1.68% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 46.92M 183.68% | 130.162M 177.41% | 160.268M 23.13% | 166.13M 3.66% | 237M 42.66% | 225.85M -4.70% | 368.47M 63.15% | 418.25M 13.51% | 550.37M 31.59% | 507.98M -7.70% | 533.31M 4.99% | |
| EBITDA YoY % growth | -74.92M 41.97% | -40.739M 45.62% | -45.719M -12.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -75.5M 34.71% | -41.13M 45.52% | -46.209M -12.35% | -36.641M 20.71% | 14.696M 140.11% | 21.643M 47.27% | 141.78M 555.08% | 184.07M 29.83% | 298.87M 62.37% | 148.34M -50.37% | 92.596M -37.58% | |
| Operating Margin | -160.91% | -31.60% | -28.83% | -22.06% | 6.20% | 9.58% | 38.48% | 44.01% | 54.30% | 29.20% | 17.36% | |
| EPS YoY % growth | -2.25 42.75% | -1.22 45.78% | -1.18 3.28% | -0.80 32.14% | 0.00 100.00% | 0.03 | 1.80 5,783.33% | 2.36 30.88% | 3.23 37.23% | 1.34 -58.68% | 0.75 -43.51% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 34.24% | -0.04 66.00% | -0.18 47.54% | -0.13 46.96% | -0.10 59.18% | 0.43 1,150.00% |
| Revenue Q2Q % growth | 39.602M 31.08% | 53.841M -28.74% | 46.053M 47.44% | 49.113M 22.80% | 51.153M 29.17% | 91.251M 69.48% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.91M 39.91% | 3.463M 222.07% | -5.967M 62.25% | -3.481M 63.01% | -1.824M 81.60% | 31.617M 812.99% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
26.53%
EPS Next 5 Year
31.93%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
14.33%
Revenue Next 5 Year
22.58%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PARATEK PHARMACEUTICALS INC / PRTK Forecast FAQ
What is the average price target for PARATEK PHARMACEUTICALS INC (PRTK) stock?
9 analysts have analysed PRTK and the average price target is 3.16 USD. This implies a price increase of 41.79% is expected in the next year compared to the current price of 2.23.
What is the next earnings date for PRTK stock?
PARATEK PHARMACEUTICALS INC (PRTK) will report earnings on 2023-11-01, before the market open.
What are the consensus estimates for PRTK stock next earnings?
The consensus EPS estimate for the next earnings of PARATEK PHARMACEUTICALS INC (PRTK) is -0.25 USD and the consensus revenue estimate is 39.60M USD.
How many analysts cover PARATEK PHARMACEUTICALS INC (PRTK) stock?
The number of analysts covering PARATEK PHARMACEUTICALS INC (PRTK) is 9.